BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28902384)

  • 21. Animal models of multiple endocrine neoplasia.
    Wiedemann T; Pellegata NS
    Mol Cell Endocrinol; 2016 Feb; 421():49-59. PubMed ID: 26184857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
    Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple endocrine neoplasia (MEN)].
    Raue F; Wilhelm T
    Radiologe; 2014 Oct; 54(10):975-80. PubMed ID: 25223437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    J Endocr Soc; 2018 Aug; 2(8):933-943. PubMed ID: 30087948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multiple Endocrine Neoplasia].
    Uchino S; Ito A
    Gan To Kagaku Ryoho; 2019 Jul; 46(7):1114-1118. PubMed ID: 31296813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updates on the genetics of multiple endocrine neoplasia.
    Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
    Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II].
    Engelbach M; Kunt T; Kann P; Manfras B; Hankeln T; Forst T; Pfützner A; Heerdt S; Walgenbach S; Lehnert H; Beyer J
    Dtsch Med Wochenschr; 2000 Jan; 125(3):37-44. PubMed ID: 10681997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and molecular aspects of multiple endocrine neoplasia.
    Wick MJ
    Clin Lab Med; 1997 Mar; 17(1):39-57. PubMed ID: 9138898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MEN for multiple endocrin neoplasms: When evokate MEN? Update 2022].
    Duval M; Haissaguerre M
    Rev Med Interne; 2023 Jan; 44(1):12-18. PubMed ID: 36307322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medullary Thyroid Carcinoma in Children.
    Graves CE; Gosnell JE
    Semin Pediatr Surg; 2020 Jun; 29(3):150921. PubMed ID: 32571506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Krampitz GW; Norton JA
    Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inherited cancer syndromes and the thyroid: an update.
    Metzger R; Milas M
    Curr Opin Oncol; 2014 Jan; 26(1):51-61. PubMed ID: 24300902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of rapid and accurate screening test for RET hotspot somatic and germline mutations in MEN2 syndromes.
    Zupan A; Glavač D
    Exp Mol Pathol; 2015 Dec; 99(3):416-25. PubMed ID: 26321248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine cancer syndromes: an update.
    Anik A; Abaci A
    Minerva Pediatr; 2014 Dec; 66(6):533-47. PubMed ID: 25243504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple Endocrine Neoplasia Syndromes: A Comprehensive Imaging Review.
    Grajo JR; Paspulati RM; Sahani DV; Kambadakone A
    Radiol Clin North Am; 2016 May; 54(3):441-51. PubMed ID: 27153782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coincidence of multiple endocrine neoplasia type 2A with acromegaly.
    Saito T; Miura D; Taguchi M; Takeshita A; Miyakawa M; Takeuchi Y
    Am J Med Sci; 2010 Oct; 340(4):329-31. PubMed ID: 20739875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
    Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
    N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.